Literature DB >> 17522474

A critical appraisal of the radiological evaluation of nephrocalcinosis.

Lara Cheidde1, Sérgio Aron Ajzen, Cecilia Helena Tamer Langen, Dejaldo Christophalo, Ita Pfeferman Heilberg.   

Abstract

BACKGROUND/AIM: The level of agreement concerning the diagnosis of nephrocalcinosis (NC) based on ultrasonography (US), computed tomography (CT) or kidney/ureter/bladder (KUB) X-ray was assessed.
METHODS: Sequences of KUB+US+CT from 62 patients, 48 with at least one exam suggesting NC and 14 with pelvicalyceal calcifications (nephrolithiasis) were reviewed twice by 3 radiologists (firstly randomized and secondly presenting KUB+US+CT of each patient together).
RESULTS: The intraobserver concordance varied from 76 to 90% for KUB, 77 to 85% for US and 82 to 89% for CT. There was a significant change in diagnosis between the 1st and 2nd reviews for observer 1 in KUB and CT, for observer 2 in US, but not for observer 3. Evaluating patients' exams together did not provide a better agreement. The highest sensitivity and specificity (92 and 89%, respectively) were only attained when 2 exams suggested NC diagnosis, being CT one of them. These enabled us to suggest that 33 out of 48 (62.5%) patients had NC (evidenced in US+CT+KUB (81.8%), US+CT (12.1%) or KUB+CT (6.1%).
CONCLUSION: The low level of concordance renders the radiological diagnosis of NC difficult. Nephrocalcinosis should be confirmed by CT combined with either US or KUB. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17522474     DOI: 10.1159/000102999

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  8 in total

Review 1.  What is nephrocalcinosis?

Authors:  Linda Shavit; Philippe Jaeger; Robert J Unwin
Journal:  Kidney Int       Date:  2015-03-25       Impact factor: 10.612

2.  Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease.

Authors:  Naeem Bhojani; Jessica E Paonessa; Tariq A Hameed; Elaine M Worcester; Andrew P Evan; Fredric L Coe; Michael S Borofsky; James E Lingeman
Journal:  J Urol       Date:  2015-05-16       Impact factor: 7.450

3.  Ultrasound is superior to computed tomography for assessment of medullary nephrocalcinosis in hypoparathyroidism.

Authors:  Alison M Boyce; Thomas H Shawker; Suvimol C Hill; Peter L Choyke; Michael C Hill; Robert James; Nancy A Yovetich; Michael T Collins; Rachel I Gafni
Journal:  J Clin Endocrinol Metab       Date:  2013-01-24       Impact factor: 5.958

4.  The influence of renal manifestations to the progression of autosomal dominant polycystic kidney disease.

Authors:  A Idrizi; M Barbullushi; E Petrela; S Kodra; A Koroshi; N Thereska
Journal:  Hippokratia       Date:  2009-07       Impact factor: 0.471

5.  Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.

Authors:  José L Nishiura; Rodrigo F C A Neves; Samara R M Eloi; Susan M L F Cintra; Sergio A Ajzen; Ita P Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

6.  Nephrocalcinosis and Nephrolithiasis in X-Linked Hypophosphatemic Rickets: Diagnostic Imaging and Risk Factors.

Authors:  Guido de Paula Colares Neto; Fernando Ide Yamauchi; Ronaldo Hueb Baroni; Marco de Andrade Bianchi; Andrea Cavalanti Gomes; Maria Cristina Chammas; Regina Matsunaga Martin
Journal:  J Endocr Soc       Date:  2019-03-25

Review 7.  Renal manifestations of sarcoidosis: from accurate diagnosis to specific treatment.

Authors:  Filipe A Saliba C Correia; Giovanni S Marchini; Fábio C Torricelli; Alexandre Danilovic; Fábio C Vicentini; Miguel Srougi; William C Nahas; Eduardo Mazzucchi
Journal:  Int Braz J Urol       Date:  2020 Jan-Feb       Impact factor: 1.541

8.  Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria.

Authors:  Xiaojing Tang; Eric J Bergstralh; Ramila A Mehta; Terri J Vrtiska; Dawn S Milliner; John C Lieske
Journal:  Kidney Int       Date:  2014-09-17       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.